drugset / Trial / NCT06281132

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

NCT06281132 ↗

Phase 1 Completed 51 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The objective was to evaluate and compare the pharmacokinetic profiles and safety after administration of test drug (CKD-341) and reference drugs (D956) in healthy adults.

Timeline

Start
2024-03-22
Primary completion
2024-05-07
Completion
2024-05-14

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-341 Unknown 1 unknown Oral
Subject D956 Unknown 1 unknown Oral

Indications